Global Growth and Distribution of CyberKnife Stereotactic Radiosurgery: A Bibliometric Analysis

CyberKnife立体定向放射外科手术的全球增长与分布:文献计量分析

阅读:2

Abstract

BACKGROUND AND OBJECTIVES: CyberKnife (CK) is advanced stereotactic radiosurgery (SRS) technology indicated for brain metastases, arteriovenous malformations, functional disease, and a number of other neurosurgical conditions that combines a linear accelerator with a highly maneuverable robotic arm and real-time imaging, allowing for several advantages including the ability to deliver radiation from a wide variety of angles and frameless delivery of therapy. We seek to explore the current trend and evolution of publications related to CK SRS using bibliometric approach, with a particular focus on neurosurgical disease applications. METHODS: The Web of Science database was queried for data collection, using keyword "CyberKnife". Network visualization figures representing exported Web of Science data were created using visualization of similarities viewer. Statistics were completed in R. RESULTS: In total, 3980 articles from 12 077 authors were identified for analysis. Annual publication number has expressed growth from 1 article in 1996 to 263 articles in 2023. Most frequently reported conditions were brain metastases, followed by vestibular schwannoma and meningiomas. The top 5 most prolific authors in the field are Andrew Muacevic, Steven D. Chang, Oliver Blanck, Christian Baues, and John R. Adler. The top 3 most prolific institutions are the University of Cologne, Stanford University, and the University of Munich. Institutional collaboration is strongest between institutions within countries. Through authorial key word analysis, we identified that articles related to pituitary adenoma, brain metastases, meningioma, hemangioma, and cavernous sinus have increased. Through the same analysis, we noticed an increase in key words potentially associated with interdisciplinary applications of CK, such as immunotherapy, machine learning, and deep learning. CONCLUSION: CK SRS is an emergent technology with increasingly more neurological conditions and diseases being researched for treatment options. The rise in academic focus on CK SRS has been spearheaded by international effort from the United States, Japan, and Italy. There remains significant potential for future international collaboration.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。